Baclofen toxicity: Difference between revisions
(Text replacement - "HTN" to "hypertension") |
(Text replacement - "AMS" to "altered mental status") |
||
| Line 7: | Line 7: | ||
*nausea and vomiting | *nausea and vomiting | ||
*Drowziness, dizziness | *Drowziness, dizziness | ||
*Seizures, delirium, | *Seizures, delirium, altered mental status, coma | ||
*Bradycardia, hypotension OR hypertension, respiratory compromise | *Bradycardia, hypotension OR hypertension, respiratory compromise | ||
*Hypothermia | *Hypothermia | ||
Revision as of 08:11, 31 July 2016
Background
- Indications include MS, muscle spasticity pain
- GABAb receptor agonist
- Most excretion is renal
Clinical Features
- nausea and vomiting
- Drowziness, dizziness
- Seizures, delirium, altered mental status, coma
- Bradycardia, hypotension OR hypertension, respiratory compromise
- Hypothermia
Differential Diagnosis
Evaluation
- Diagnosis of exclusion
Management
- Activated charcoal for recent ingestion
- Supportive care:
- IV fluids, respiratory care
- Vasopressors for persistent hypotension
- Benzodiazepines for seizures
- Hemodialysis for very severe toxicity
Disposition
See Also
References
- Jung, M. “Baclofen Overdoses”. Maryland Poison Center, University of Maryland School of Pharmacy. www.mdpoison.com Accessed April 29th, 2014.
- Nicola Y Leung, Ian M Whyte, Geoffrey K Isbister Baclofen overdose: defining the spectrum of toxicity. Emerg Med Australas: 2006, 18(1);77-82